Why These Stocks Are Tanking Today
The decline of the U.S. stocks is continuing for the third day straight, after disappointing economic data put downward pressure on the market.
Mannkind Corp (MNKD)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Why Are These Five Stocks on the Move Today?
With the broader market down by more than half a percent, shares of International Game Technology Ordinary Shares (NYSE:IGT), Freshpet Inc (NASDAQ:FRPT), Advance Auto Parts, Inc.
Why Are These Five Stocks Losing Ground on Tuesday?
The US stock market inched down on Tuesday amid concerns regarding the Chinese economy and a coming rate hike.
Why Are Investors Selling Shares of These Four Companies?
On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (NASDAQ:MNKD), Team Health Holdings LLC (NYSE:TMH), and...
The Future of MannKind
Shares of MannKind Corporation (NASDAQ:MNKD) got crushed on Wednesday, ending the day down by 10.07%, on the back of a research note published by Piper Jaffray analyst Joshua E.
Jason Karp Hates MannKind Corporation (MNKD), Likes NCR Corporation, Ctrip.com International, Ltd. (ADR) (CTRP)
According to CNBC, Tourbillon Capital's Jason Karp is betting on a decline of MannKind Corporation (NASDAQ:MNKD) shares.
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What's MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors
In pharmacology, we don't only have to consider the actions of the drug on the body. It is also important to understand the way the body processes the drug, or the pharmacokinetics.
MannKind Corporation (MNKD), Pfizer Inc. (PFE): Why Afrezza May Not Work
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration in 2011 for...
MannKind Corporation (MNKD) News: Healthcare Conference, Executives, FAQ list & More
MannKind Corporation, focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at The Morgan Stanley Global Healthcare Conference on Tuesday...
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
